Nova Scotia Health Authority
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nshealth.ca
Effect of High-Flow Nasal Cannula on IVC Measurements Using Point of Care Ultrasound
- First Posted Date
- 2022-03-03
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Nova Scotia Health Authority
- Registration Number
- NCT05264454
- Locations
- 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 30
- Registration Number
- NCT05259137
A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-01-10
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 440
- Registration Number
- NCT05182008
- Locations
- 🇨🇦
QEII Health Sciences Center, Halifax, Nova Scotia, Canada
TES RCT Fleet Enema vs Oral Mechanical Bowel Prep
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 66
- Registration Number
- NCT05148494
- Locations
- 🇨🇦
Victoria General Hospital, Halifax, Nova Scotia, Canada
Optimal Management of Extreme Obesity and Severe Knee Osteoarthritis Feasibility Trial
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 20
- Registration Number
- NCT05120492
- Locations
- 🇨🇦
Nova Scotia Health, Halifax, Nova Scotia, Canada
Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-11-11
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 30
- Registration Number
- NCT05116995
- Locations
- 🇨🇦
Nova Scotia Health, Halifax, Nova Scotia, Canada
The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 24
- Registration Number
- NCT05116137
- Locations
- 🇨🇦
QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-11-08
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 120
- Registration Number
- NCT05111067
- Locations
- 🇨🇦
Nova Scotia Health, Halifax, Nova Scotia, Canada
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 60
- Registration Number
- NCT05024162
- Locations
- 🇨🇦
Victoria General Hospital, Halifax, Nova Scotia, Canada
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Nova Scotia Health Authority
- Target Recruit Count
- 400
- Registration Number
- NCT05017311
- Locations
- 🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇨🇦University of Calgary, Calgary, Alberta, Canada
🇨🇦Queen's University, Kingston, Ontario, Canada
© Copyright 2024. All Rights Reserved by MedPath